End-of-Life Care for Patients With Advanced Ovarian Cancer Is Aggressive Despite Hospice Intervention: A Population-Based Study.

摘要: Objective To date, few studies have examined end-of-life (EOL) care and healthcare costs for patients with ovarian cancer. We evaluated the effects of hospice on quality EOL cancer in final month life. Materials Methods conducted a population-based study analyzed data from Taiwan9s Longitudinal Health Insurance Database, which contains claims information medical records patients, costs, insurance system exit dates: our proxy death between 1997 2011. Results A total 176 women who died were investigated. Of these 32 (18.2%) had received care. Univariate analysis revealed that (H group) lower proportions intensive unit admission (0% vs 15.3%) cardiopulmonary resuscitation 18.1%). The mean health cost per person during life H group was approximately 5.5% significantly higher than without (non-H (US $3121 ± $376 $2957 $347). admission, receipt resuscitation, more 1 emergency room visit could not be assessed because no cases 3 occurrences observed among by multivariate regression model. No significant difference non-H groups terms chemotherapy 2 weeks probabilities hospitalization acute hospitals after adjusting confounders. Conclusions aggressiveness offset advanced factors hospitalizations dying hospital warrant further investigation.